CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer

BACKGROUND: Lung cancer (LC) is the leading type of cancer worldwide, yet it’s challenging to detect early LC. Therefore, it is valuable to explore diagnostic biomarker that can distinguish malignant pulmonary lesions from benign diseases. The potential role of plate factor-4 variant (CXCL4L1) will...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lei, Li, Guangping, Zhang, Hongxin, Liu, Huaqun, Li, Songlin, Wang, Yanan, Qi, Huisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188318/
https://www.ncbi.nlm.nih.gov/pubmed/35698601
http://dx.doi.org/10.2147/CMAR.S352217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188318/
https://www.ncbi.nlm.nih.gov/pubmed/35698601
http://dx.doi.org/10.2147/CMAR.S352217

Ejemplares similares